- Published on
Ophthalmology – Brown Syndrome
Brown syndrome is an ocular motility disorder characterized by a restriction of elevation when the eye is in adduction. This limitation may occur with both active and passive movement and is typically caused by abnormal function of the superior oblique tendon–trochlea complex. The condition can be congenital or acquired and varies in severity from mild limitation to complete restriction of elevation in adduction.
Epidemiologically, Brown syndrome is relatively uncommon, occurring in approximately 1 in 450 cases of strabismus. It can present at any age, though congenital cases are often detected in childhood, while acquired cases may occur later in life due to trauma or inflammatory conditions. Rare familial cases with autosomal dominant inheritance have been reported.
The pathophysiology involves mechanical restriction of the superior oblique tendon as it passes through the trochlea. Normally, the tendon glides smoothly, allowing coordinated eye movement. In Brown syndrome, the tendon may be tight, inelastic, inflamed, or mechanically restricted, preventing normal elevation of the eye in adduction. This distinguishes it from neurogenic causes of motility limitation, as the issue is mechanical rather than due to muscle weakness.
Etiologically, congenital cases are typically due to a short or inelastic superior oblique tendon. Acquired cases may result from trauma to the tendon or trochlea, or from inflammatory conditions such as Juvenile Idiopathic Arthritis or Rheumatoid Arthritis. Inflammatory cases may present with pain, swelling, and tenderness in the superonasal orbit.
Patients may present with abnormal eye movements, particularly difficulty looking upward when the eye is turned inward. Diplopia may occur in upgaze, especially in acquired cases. Some patients report a clicking sensation with attempted elevation. To compensate, individuals may adopt a chin-up posture or turn their face away from the affected eye to maintain binocular vision. On examination, there is limited elevation in adduction with normal elevation in abduction. A hypotropia may be present in primary gaze or in gaze away from the affected side, and in acquired cases, tenderness or swelling over the trochlear region may be noted.
Diagnosis is primarily clinical, supported by findings such as a positive forced duction test indicating mechanical restriction. Imaging such as MRI may show inflammation or enhancement in the trochlear region in acquired cases but is not required for diagnosis. Laboratory evaluation may be indicated when an inflammatory cause is suspected, including tests for autoimmune disease.
Management depends on the cause and severity. Many congenital cases do not require treatment, as patients adapt well without significant symptoms. In acquired inflammatory cases, treatment of the underlying condition often leads to resolution. Nonsteroidal anti-inflammatory drugs may be used initially, with corticosteroids or local steroid injections considered for persistent inflammation.
Surgical intervention is reserved for patients with significant head posture, hypotropia in primary gaze, or troublesome diplopia. Procedures aim to relieve the restriction of the superior oblique tendon, such as tenotomy or tendon lengthening techniques, while minimizing the risk of postoperative complications like inferior oblique overaction.
The prognosis is generally good. Congenital cases often remain stable and may not require intervention, while acquired cases—especially those related to inflammation—frequently resolve with appropriate medical management. Long-term follow-up is important to monitor for amblyopia, persistent diplopia, or changes in ocular alignment.
0 Comments
